<code id='31E9611CD1'></code><style id='31E9611CD1'></style>
    • <acronym id='31E9611CD1'></acronym>
      <center id='31E9611CD1'><center id='31E9611CD1'><tfoot id='31E9611CD1'></tfoot></center><abbr id='31E9611CD1'><dir id='31E9611CD1'><tfoot id='31E9611CD1'></tfoot><noframes id='31E9611CD1'>

    • <optgroup id='31E9611CD1'><strike id='31E9611CD1'><sup id='31E9611CD1'></sup></strike><code id='31E9611CD1'></code></optgroup>
        1. <b id='31E9611CD1'><label id='31E9611CD1'><select id='31E9611CD1'><dt id='31E9611CD1'><span id='31E9611CD1'></span></dt></select></label></b><u id='31E9611CD1'></u>
          <i id='31E9611CD1'><strike id='31E9611CD1'><tt id='31E9611CD1'><pre id='31E9611CD1'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:comprehensive    Page View:442

          Editor’s note: A recording of the event is embedded below.

          After a few go-go years, the early-stage biotech market has cooled considerably. Two VCs will weigh in on what distinguishes great science from bad investments.

          advertisement

          Featured Speakers

          • Irena Melnikova, Ph.D., partner, Pfizer Ventures
          • Rakhshita Dhar, senior director, venture investments, Leaps by Bayer
          • Frank S. David, M.D., Ph.D., managing director, Pharmagellan (moderator)

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          knowledge

          Bright Health sells Medicare Advantage business to Molina
          Bright Health sells Medicare Advantage business to Molina

          BrightHealthisofficiallyleavingthehealthinsurancemarket.ThecompanyhasagreedtosellitsMedicareAdvantag

          read more
          Doctors have an ethical obligation to be advocates
          Doctors have an ethical obligation to be advocates

          PhysicianCaitlinBernard,left,sitsbetweenattorneysJohnHooverandAliceMoricalonMay25,2023,beforeahearin

          read more
          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more

          FDA approves first blood sugar monitor without finger pricks

          TheFDAhasapprovedadevicefromAbbottthatcontinuouslymonitorsdiabetics’bloodsugarlevelswithoutrequiring